Journal of Oral and Maxillofacial Surgery
Volume 67, Issue 11 , Pages 2337-2343 , November 2009

Effects of Recombinant Human Erythropoietin on Mandibular Distraction Osteogenesis

  • Ahmet Mihmanli, PhD

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Selcuk University, Konya, Turkey
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Mihmanli: Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Selcuk University, 42079 Kampus, Konya, Turkey
    • ,
  • Dogan Dolanmaz, PhD

      Affiliations

    • Professor, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Selcuk University, Konya, Turkey
    • ,
  • Mustafa C. Avunduk, MD

      Affiliations

    • Professor, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Selcuk University, Konya, Turkey
    • ,
  • Esra Erdemli, MD

      Affiliations

    • Professor, Department of Histology and Embryology, Faculty of Dentistry, Ankara University, Ankara, Turkey

References 

  1. Terheyden H, Wang H, Warnke PH, et al. Acceleration of callus maturation using rhOP-1 in mandibular distraction osteogenesis in a rat model. Int J Oral Maxillofac Surg. 2003;32:528
  2. Clark CL, Strider J, Hall C, et al. Distraction osteogenesis in irradiated rabbit mandibles with adjunctive hyperbaric oxygen therapy. J Oral Maxillofac Surg. 2006;64:589
  3. Kitoh H, Kitakoji T, Tsuchiya H, et al. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis—A preliminary result of three cases. Bone. 2004;35:892
  4. Little DG, Comell MS, Briody J, et al. Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis (A study in immature rabbits). J Bone Joint Surg [Br]. 2001;83:1069
  5. Pampu AA, Dolanmaz D, Tuz HH, et al. Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis. J Oral Maxillofac Surg. 2006;64:1232
  6. Okazaki H, Kurokawa T, Nakamura K, et al. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int. 1999;64:542
  7. Raschke MJ, Bail H, Windhagen HJ, et al. Recombinant growth hormone accelerates bone regenerate consolidation in distraction osteogenesis. Bone. 1999;24:81
  8. Sato W, Matsushita T, Nakamura K. Acceleration of increase in bone mineral content by low-intensity ultrasound energy in leg lengthening. J Ultrasound Med. 1999;18:699
  9. Hagino T, Hamada Y. Accelerating bone formation and earlier healing after using demineralized bone matrix for limb lengthening in rabbits. J Orthop Res. 1999;17:232
  10. Al Ruhaimi KA. Effect of calcium sulphate on the rate of osteogenesis in distracted bone. Int J Oral Maxillofac Surg. 2001;30:228
  11. Danis A. Mechanism of bone lengthening by the Ilizarov technique. Bull Mem Acad R Med Belg. 2001;156:107
  12. Miloro M, Miller JJ, Stoner JA. Low-level laser effect on mandibular distraction osteogenesis. J Oral Maxillofac Surg. 2007;65:168
  13. Kendall RG. Erythropoietin. Clin Lab Haematol. 2001;23:71
  14. Buemi M, Vaccaro M, Sturiale A, et al. Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps. Acta Derm Venereol (Stockh). 2002;82:411
  15. Galeano M, Altavilla D, Cucinotta D, et al. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes. 2004;53:2509
  16. Haroon ZA, Amin K, Jiang X, et al. A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol. 2003;163:993
  17. Buemi M, Galeano M, Sturiale A, et al. Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds. Shock. 2004;22:169
  18. Mancini DM, Katz SD, Lang CC, et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;21:294
  19. Fearon JA, Weinthal J. The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children. Plast Reconstr Surg. 2002;109:2190
  20. McDougall IC, Cavill I, Davies ME, et al. Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients. Contrib Nephrol. 1989;76:219
  21. McMahon FG, Vargas R, Ryan M, et al. Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers. Blood. 1990;76:718
  22. Brown AL, Tucker B, Baker LRI, et al. Seizures related to blood transfusion and erythropoietin treatment in patients undergoing dialysis. Br Med J [Clin Res]. 1989;299:1258
  23. Okazaki H, Kurokawa T, Nakamura K, et al. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int. 1999;64:542
  24. Little DG, Smith NC, Williams PR, et al. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res. 2003;18:1300

PII: S0278-2391(08)01156-7

doi: 10.1016/j.joms.2008.06.082

Journal of Oral and Maxillofacial Surgery
Volume 67, Issue 11 , Pages 2337-2343 , November 2009

Article Tools

* Image Usage & Resolution